All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response

BACKGROUND: Hepatitis C virus (HCV) infection is the major cause of end-stage liver disease (LD) worldwide. The aim of this study was to assess sustained virological response (SVR) rates in a real-world cohort of patients with HCV infection treated with interferon-free direct antiviral agents (DAA)....

Descripción completa

Detalles Bibliográficos
Autores principales: Miotto, Noelle, Mendes, Leandro Cesar, Zanaga, Leticia Pisoni, Lazarini, Maria Silvia Kroll, Goncales, Eduardo Sellan Lopes, Pedro, Marcelo Nardi, Goncales, Fernando Lopes, Stucchi, Raquel Silveira Bello, Vigani, Aline Gonzalez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038991/
https://www.ncbi.nlm.nih.gov/pubmed/29990371
http://dx.doi.org/10.1371/journal.pone.0199941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038991/
https://www.ncbi.nlm.nih.gov/pubmed/29990371
http://dx.doi.org/10.1371/journal.pone.0199941

Ejemplares similares